Long-term safety of cantharidin gel for common warts
Part of Infections, Skin clinical trials.
This study follows people who completed an earlier cantharidin trial to see how safe and effective the medicine is over a longer time. You may join if you still have treatable warts or finished the earlier study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Completed a previous cantharidin study and still have at least one treatable common wart, or finished the last visit of that study.
- Agree not to swim, bathe, or soak in water until the study drug is removed after each treatment.
- Willing to avoid other wart-removal products, except for certain warts not being treated in this study (like genital, plantar, or anal warts).
- Not currently taking strong immune-suppressing drugs (like oral steroids) or have a weakened immune system.
- Not pregnant, breastfeeding, or planning to become pregnant, and willing to use effective birth control if sexually active.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called cantharidin for treating common warts. It is for people age 2 and older who are generally healthy and have at least one common wart on the body (but not on palms, soles, face, or genitals). Participants cannot use other wart treatments during the study.
This trial tests a medicated liquid called cantharidin for treating common warts on the body (not on the face, soles, or private areas). The liquid is painted on by a doctor and later removed, and the goal is to see if it clears warts safely.
This Phase 2 study tests giving a Candida antigen plus a bivalent HPV vaccine to help shrink or clear multiple common skin warts. It may help people with warts on different body areas, with different sizes or how long they’ve had them.
This study tests whether an HPV vaccine can help shrink or clear cutaneous (skin) warts that have not responded to prior treatments. Participants get the study vaccine or a placebo to compare results and safety.
This trial tests whether applying heat combined with a common disinfectant (hydrogen peroxide) can safely and effectively remove viral skin warts. It may be an option if you have common, plantar, or genital warts and are between 16 and 65 years old.
This study tests a new way to treat common warts by injecting vitamin D directly into the wart. It may help your immune system clear the warts with minimal side effects.
Hear when a new Common Warts (Verruca Vulgaris) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.